Evidence for microtubule nucleation at the Golgi in breast cancer cells
Cytoskeleton · 2024
DOI: 10.1002/cm.21803 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytoskeleton, 2024. Verfasst von Laura A Zahn und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Microtubules, Golgi Apparatus, Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Golgi‐derived microtubule (MT) arrays are essential to directionally persistent cell migration and vesicle transport. In this study, we have examined MT nucleation sites in two breast cancer cell lines, MDA‐MB‐231 and MCF‐7, with the hypothesis that only the migratory invasive MDA‐MB‐231 cells exhibit MTs originating from the Golgi. MTs were disassembled and allowed to slightly regrow so individual nucleation sites could then be observed via fluorescently tagged antibodies (α‐tubulin, cis ‐Golgi marker GM130, and EB1—a MT plus‐end binding protein) and confocal microscopy. To determine if MT nucleation at the Golgi is more apparent during active migration compared to when cells are stationary, cells were treated with the chemoattractant epidermal growth factor (EGF) and examined for colocalizations between the Golgi, α‐tubulin, and γ‐tubulin. Images were analyzed qualitatively for color overlap, and quantitatively using Manders Colocalization Coefficients. Differences between groups were tested for significance using one‐way analysis of variances and Tukey's post hoc test. Significantly higher colocalization values (coloc) in the highly invasive MDA‐MB‐231 cells (α‐tubulin coloc GM130 = 0.39, GM130 coloc α‐tubulin = 0.82, GM130 coloc EB1 = 0.24, and EB1 coloc GM130 = 0.38) compared to the weakly invasive MCF‐7 cells (0.15, 0.08, 0.02, and 0.16, respectively) were observed. EGF‐treated cells exhibited higher colocalization values than control cells for three of the four protein combinations tested, but EGF‐treated MDA‐MB‐231 cells exhibited significantly higher values (α‐tubulin coloc GM130 = 0.20, GM130 coloc α‐tubulin = 0.89, and γ‐tubulin coloc GM130 = 0.47) than both control groups as well as the EGF‐treated MCF‐7 cells. Results support the hypothesis that MT nucleation at the Golgi occurs more frequently in the invasive MDA‐MB‐231 cell line compared to the weakly invasive MCF‐7 cells. The presence or absence of Golgi‐derived MTs may help to explain the difference in migratory potential commonly exhibited by these two cell lines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Biology, Austin Peay State University, Clarksville, Tennessee, USA.
Zitieren
APA
Zahn, L. A., & Lundin-Schiller, S. (2024). Evidence for microtubule nucleation at the Golgi in breast cancer cells. Cytoskeleton. https://doi.org/10.1002/cm.21803
Vancouver
Zahn LA, Lundin-Schiller S. Evidence for microtubule nucleation at the Golgi in breast cancer cells. Cytoskeleton. 2024. doi:10.1002/cm.21803
BibTeX
@article{Zahn2024,
author = {Zahn, Laura A and Lundin-Schiller, Sarah},
title = {Evidence for microtubule nucleation at the Golgi in breast cancer cells},
journal = {Cytoskeleton},
year = {2024},
doi = {10.1002/cm.21803}
}
EUVIMED